Skip to main content
Cloudbreak Pharma Inc. logo

Cloudbreak Pharma Inc. - Investor Relations & Filings

Listed IPO Jul 2025
Ticker · 2592 ISIN · KYG2215S1084 HKEX Manufacturing
Open in API
Filings indexed 87 across all filing types
Latest filing 2026-07-17 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2592 · 1 venue

About Cloudbreak Pharma Inc.

https://cloudbreakpharma.com/

Cloudbreak Pharma Inc. is an innovative, clinical-stage ophthalmology biotechnology company dedicated to the research and development of novel and differentiated treatments for chronic eye diseases. The company focuses on improving vision quality globally by developing therapies for both anterior and posterior segment ophthalmic conditions. Its robust pipeline includes products targeting pterygium, pinguecula, meibomian gland dysfunction, glaucoma filtration surgery, age-related macular degeneration, and diabetic retinopathy. Cloudbreak utilizes advanced platforms, including a potent multi-kinase inhibitor formulated as a topical eye drop for anterior segment diseases and a unique Antibody-Drug Synergism Platform for posterior segment diseases.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE IN RELATION TO INVESTIGATIONAL NEW DRUG APPLICATION FOR CBT-358 COMPLETION OF SAFETY REVIEW BY THE FOOD AND DRUG ADMINISTRATION OF THE UNITED STATES OF AMERICA
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement regarding a business update on an investigational new drug application (IND) for CBT-358, specifically noting the completion of a safety review by the US FDA. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general regulatory announcement regarding company business developments that does not fall into the other specialized categories, it is classified as a Regulatory Filing (RNS).
2026-07-17 English
CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the resignation of a company secretary and the appointment of a new one. This falls under the category of changes in senior management or key corporate officers. According to the provided definitions, announcements regarding changes in the board or senior management are classified as 'MANG'.
2026-07-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026
Regulatory Filings Classification · 100% confidence The document is a 'Monthly Return of Equity Issuer on Movements in Securities' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This is a standard regulatory filing required by the HKEX Listing Rules to report monthly changes in a company's share capital, such as share issues, options, or treasury share movements. It does not fit into financial report categories like 10-K or IR, nor is it an earnings release or a simple announcement. It is a recurring regulatory compliance document, which falls under the 'Regulatory Filings' (RNS) category.
2026-07-06 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details specific changes in the company's issued share capital resulting from the allotment of new shares under various equity incentive schemes. This type of filing is a standard regulatory requirement for listed companies in Hong Kong to report changes in share capital, which falls under the 'Share Issue/Capital Change' category.
2026-07-03 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a 'Next Day Disclosure Return' (Form FF305) filed with the Hong Kong Stock Exchange. It details a specific change in the company's issued share capital resulting from the allotment of new shares under an equity incentive scheme. This type of filing is a regulatory requirement for listed issuers to report changes in share capital, which falls under the 'Share Issue/Capital Change' category.
2026-06-30 English
VOTING RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2026 ANNUAL GENERAL MEETING
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'VOTING RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2026 ANNUAL GENERAL MEETING'. It explicitly details the results of the poll conducted at the AGM, including the number of votes for and against each resolution, and confirms that all resolutions were passed. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-06-26 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.